Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib
Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer
Suggestive increases for prostate and colorectal cancer mortality observed with more years as a firefighter
FDA Approves Empaveli for Rare Kidney Diseases
Approval is first treatment for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis
Suboptimal Dialysis Initiation Common in Patients With Advanced CKD
Higher comorbidity index, greater number of nephrologist visits within past six months linked to higher risk for suboptimal dialysis initiation
CKD May Be Tied to Higher Risk for Tooth Loss
After adjustment for multiple confounding variables, chronic kidney disease linked to having fewer than 20 teeth
Standardization Needed for Dialysis Initiation in Pregnancy
Women who started dialysis during pregnancy more often had adverse maternal and fetal outcomes
Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients
Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than two years
Atopic Dermatitis May Be Linked to Increased Risk for CKD
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
Public Health Response Data Show Success of Standard Infection Control Measures for Dialysis
Standard IPC measures enabled safe provision of dialysis to patients with C. auris colonization or infection, without transmission
FDA Publishes Full Texts of Response Letters to Drug Applications
The goal is to improve public understanding of the FDA decision-making process
